Many analysts agree that the industry is moving from the era of the "blockbuster drug" to a new operating model known as personalized medicine.
PricewaterhouseCoopers has extensive experience working with organizations across the industry, including, proprietary and generic drug manufacturers, specialty drug makers, medical device and diagnostics suppliers, biotechnology companies, wholesalers, pharmacy benefit managers, contract research organizations, and industry associations. We have aligned our practice with the broader health industries market to ensure that our people are well versed in the relationships between suppliers, providers, payers, and customers.
